Dicofol (CASRN 115-32-2)
view QuickView

0324
Dicofol; CASRN 115-32-2
Health assessment information on a chemical substance is included in IRIS only after a comprehensive review of chronic toxicity data by U.S. EPA health scientists from several Program Offices and the Office of Research and Development. The summaries presented in Sections I and II represent a consensus reached in the review process. Background information and explanations of the methods used to derive the values given in IRIS are provided in the Background Documents.
STATUS OF DATA FOR Dicofol
File First On-Line 08/22/1988
Category (section) |
Status |
Last Revised |
---|---|---|
Oral RfD Assessment (I.A.) | no data | |
Inhalation RfC Assessment (I.B.) | no data | |
Carcinogenicity Assessment (II.) | withdrawn | 07/01/1993 |
_I. Chronic Health Hazard Assessments for Noncarcinogenic Effects
_I.A. Reference Dose for Chronic Oral Exposure (RfD)
Substance Name — Dicofol
CASRN — 115-32-2
Not available at this time.
_I.B. Reference Concentration for Chronic Inhalation Exposure (RfC)
Substance Name — Dicofol
CASRN — 115-32-2
Not available at this time.
_II. Carcinogenicity Assessment for Lifetime Exposure
Substance Name — Dicofol
CASRN — 115-32-2
The carcinogen assessment summary for this substance has been withdrawn pending further review by the CRAVE Agency Work Group.
Agency Work Group Review — 06/03/1987, 06/24/1987, 08/05/1987, 12/04/1991, 06/02/1992
Screening-Level Literature Review Findings — A screening-level review conducted by an EPA contractor of the more recent toxicology literature pertinent to the cancer assessment for Dicofol conducted in September 2002 did not identify any critical new studies. IRIS users who know of important new studies may provide that information to the IRIS Hotline at hotline.iris@epa.gov or (202)566-1676.
EPA Contacts:
Please contact the IRIS Hotline for all questions concerning this assessment or IRIS, in general, at (202)566-1676 (phone), (202)566-1749 (FAX) or hotline.iris@epa.gov (internet address).
_III.
[reserved]
_IV. [reserved]
_V. [reserved]
_VI. Bibliography
Substance Name — Dicofol
CASRN — 115-32-2
Not available at this time.
_VII. Revision History
Substance Name — Dicofol
CASRN — 115-32-2
Date |
Section |
Description |
---|---|---|
08/22/1988 | II. | Carcinogen summary on-line |
01/01/1990 | VI. | Bibliography on-line |
01/01/1992 | II. | Carcinogen assessment noted as pending change |
01/01/1992 | IV. | Regulatory Action section on-line |
04/01/1992 | II. | Carcinogen assessment withdrawn pending further review |
04/01/1992 | IV. | Withdrawn; no assessments on-line |
04/01/1992 | VI. | Bibliography withdrawn; no assessments on-line |
07/01/1992 | II. | Work group review dates added |
07/01/1993 | II. | EPA contact changed |
08/01/1995 | II., IV.,VI. | EPA's RfD/RfC and CRAVE workgroups were discontinued in May, 1995. Chemical substance reviews that were not completed by September 1995 were taken out of IRIS review. The IRIS Pilot Program replaced the workgroup functions beginning in September, 1995. |
04/01/1997 | III., IV., V. | Drinking Water Health Advisories, EPA Regulatory Actions, and Supplementary Data were removed from IRIS on or before April 1997. IRIS users were directed to the appropriate EPA Program Offices for this information. |
12/03/2002 | II. | Screening-Level Literature Review Findings message has been added. |
_VIII. Synonyms
Substance Name — Dicofol
CASRN — 115-32-2
Last Revised — 08/22/1988
- 115-32-2
- acarin
- Dicofol
- DTMC
- FW293
- kelthane
- mitigan